
MedChemExpress
@MedChemExpress
Followers
430
Following
2K
Media
1K
Statuses
9K
Committed to supporting innovative research Inhibitors, Proteins, Screening Libraries & more to further research Learn more โคต https://t.co/NlSVcuDiTc
United States
Joined January 2014
๐ต Campus Music Festivals๐ฑ.โ๏ธ Sunshine, green grass and the sound of live musicโour campus turned into a music paradise! .๐ค Youth sounds loud, passionate, and unforgettable. ๐ฌ Share your favorite campus music festival memories!.#StudentLife #SummerFestival #GraduationSeason
0
0
0
๐งซThe tumor microenvironment (TME) is a major hurdle for effective immunotherapy! .๐งชHow do we analyze TME in breast cancer? .๐What are the key cell and animal models for breast cancer research? .๐Learn morel: #Cancer #BreastCancer #CancerResearch
0
0
0
๐ CD81 is a key marker of extracellular vesicles (EVs) in Parkinson's research! This finding could lead to better diagnosis and treatment strategies. Discover more: #Parkinsons #CD81 #Research #Neuroscience.
0
0
0
โญ "New Nature study maps PTSD-linked molecular changes in inhibitory neurons, endothelial cells, and microglia, implicating glucocorticoid signaling, GABAergic transmission, and neuroinflammation. Spatial transcriptomics validates disrupted genes like SST and FKBP5. #PTSD
1
0
1
๐จโ๐ฌ Docetaxel, a microtubule depolymerization inhibitor, shows promise in prostate cancer research! This treatment option could significantly improve patient outcomes.๐ Discover more: #ProstateCancer #Docetaxel #CancerResearch.
0
0
0
๐ GSK8612, a highly selective TBK1 inhibitor, shows promise in renal fibrosis research! This breakthrough could lead to new treatment options for patients. Find out more: #RenalFibrosis #GSK8612 #ResearchInnovation.
0
0
0
๐ข MedChemExpress LLC's #New #Products for May are now available!.This month, we've added over 1,000 cutting-edge bioactive molecules, expanding support for hot research areas like #cancer, #neurologicaldisorders, #immunoinflammation, #metabolicdiseases, and
0
0
1
๐ Onvansertib, a PLK1 inhibitor, shows potential for endometrial cancer treatment! This breakthrough could enhance patient outcomes by targeting key tumor growth pathways. Learn more: #CancerResearch #EndometrialCancer #Onvansertib.
0
0
0
๐ฌ Volasertib: A PLK1 Inhibitor for Solid Tumors! ๐๐ For more detailed information๏ผ#Volasertib #CancerResearch #Oncology.
0
0
0
๐ Corylin: An HSP90ฮฒ Inhibitor for Metabolic Diseases! ๐ This innovative compound shows promise in understanding and treating metabolic disorders. ๐ For more detailed information: Exciting advancements in research ahead!.#Corylin #MetabolicDiseases.
0
0
1